Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Long QT Syndrome (LQTS) 2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Honor Health Research and Innovation Institute, Scottsdale, Arizona, United States
University of California San Francisco, San Francisco, California, United States
University of Illinois Chicago, Chicago, Illinois, United States
Heart Center Clinical Research Program | MGH, Boston, Massachusetts, United States
University of Michigan, Arbor, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
NYU Langone Health, New York, New York, United States
Wilmington Health, Wilmington, North Carolina, United States
Oregon Health & Science University, Portland, Oregon, United States

View source on ClinicalTrials.gov